Synopsis The antiviral nucleoside analogue ganciclovir has demonstrated in vitro activity
against human cytomegalovirus and effectively treats infection caused by this organism in …

Synopsis Ganciclovir is a nucleoside analogue with antiviral activity in vitro against
members of the herpes group and some other DNA viruses. It has demonstrated efficacy …

Ganciclovir is a nucleoside guanosine analogue which incorporates ganciclovir
triphosphate (the active moiety) into DNA during elongation, thereby inhibiting viral …

Ganciclovir is a congener of acyclovir with in vitro activity against cytomegalovirus. Ninety-
seven patients with the acquired immune deficiency syndrome (AIDS) and a serious …

Ganciclovir is a nucleoside analogue which is used to treat and prevent cytomegalovirus
(CMV) infection. Most recent clinical studies of ganciclovir in transplant recipients have …

The efficacy and safety of ganciclovir were evaluated for the treatment of 39 life-threatening
or sight-threatening cytomegalovirus (CMV) infections in recipients of bone marrow …

A total of 314 immunocompromised patients with serious cytomegalovirus (CMV) infection
treated with ganciclovir administered intravenously were studied. Rates of favorable clinical …

Ganciclovir is a nucleoside analog which inhibits the replication of herpesviruses in vitro and
which has been effective by intravenous administration for the treatment of severe …

Thirty-one immunocompromised patients with severe cytomegalovirus (CMV) disease were
treated with intravenous ganciclovir. Twenty-one patients had received transplants—15 …

Ganciclovir is an experimental antiviral drug with activity against human cytomegalovirus
(CMV). Forty patients with acquired immune deficiency syndrome (AIDS) and CMV …